期刊文献+

不同检测系统检测肿瘤标志物的可比性和偏倚评估分析 被引量:5

Comparative study on the tumor markers results from different detection system
原文传递
导出
摘要 目的:探讨两个不同检测系统对肿瘤标志物(AFP、CEA、CA125、CA199)的测定结果是否存在可比性。方法:采用EP9-A方案对两个不同检测系统检测的肿瘤标志物结果进行比对和偏差评估。结果:研究表明此两个检测系统的AFP、CEA和CA125检测结果具有可比性,而CA199的检测结果在两个检测系统存在很大的偏差,不能被接受。结论:在一个实验室内不同检测系统检测肿瘤标志物务必进行结果比对和偏差评估,以确保其结果的可比性。 Objective:To discuss the comparability level for the results of four tumor markers including AFP,CEA,CA125 and CA199,measured by two different detection system.Methods: The results of four tumor markers was investigated by method comparison and bias estimation according to the NCCLS Document Ep9-A.Results: The comparability of tumor markers results in two kinds of detecting system accorded to evaluation of clinical acceptability except CA199.Conclusion: In order to insure the accuracy of the test outcome,method comparison and bias estimation should be actualized when there are more than two systems for the same test are used in a laboratory.
出处 《中国卫生检验杂志》 CAS 2010年第12期3319-3320,共2页 Chinese Journal of Health Laboratory Technology
基金 温州市科技局资助项目(2008S0229)
关键词 肿瘤标志物 方法比对 偏差评估 Tumor markers Method comparison Bias estimation
  • 相关文献

参考文献2

  • 1王兰兰.临床免疫学与检验[M].第4版.北京:人民卫生出版社2008:249-264.
  • 2National Committee for clinical laboratory standards. EP9 - A Methord comparison and bias estimation using patient samples [ S ]. Wayne, PA : NCCLS. 1995.

共引文献7

同被引文献22

  • 1魏吴 丛玉隆.医学实验室质量管理与认可指南[M].北京:中国计量出版社,2004.27-80.
  • 2National Committee for Clinical Laboratory Standards. Method comparison and bias estimation using patient samples [ S ]. EP9-A2, NCCLS, 2002.
  • 3The national committee for clinical laboratory standards. EPg-A2 Method comparison and bias estimation using patient samples [ S ]. Wanye: PA, 2002.
  • 4Wang WJ, Tao Z, Gu W, et al. Clinical observations on the associ- ation between diagnosis of lung cancer and serum tumor markers in combination[J]. Asian Pac J Cancer Prev, 2013, 14(40) : 4369 - 4371.
  • 5Jansen N, Coy ,IF. Diagnostic use of epitope detection in monocytes blood test for early detection of colon cancer metastasis[ J]. Future Oncol, 2013, 9(4): 605-609.
  • 6Lin J, Chu P, Wei Z. A new dual immunoassay for tumor marker sbased on chemiluminescence signal amplification by magnetic me- soporous silica and enzyme modified gold nanoparticles[ J]. Anals- ci, 2012, 28(1) : 21 -25.
  • 7中华人民共和国卫生部.医疗机构l临床实验室管理办法[z].2006-06-01.
  • 8CLSI. User Protocol for Evaluation of Qualitative TestPerformance; Approved Guideline: EP12-A[S]. Wayne, PA:CLSI, 2000.
  • 9Charuruks N, Laohajinda B,Rujiwanitgun S, et al.Reference value for C-reactive protein and its distributionpattern in thai adults [J]. Circ J, 2005, 69(3): 339-344.
  • 10Tomoda H,Aoki N. Prognostic value of C-reactive proteinlevels within six hours after the onset of acute myocardialinfarction[J]. Am Heart J, 2000,140(2): 324-328.

引证文献5

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部